Actual pharmacological biotechnological innovations to improve the quality of patient’s life therapeutic and surgical profile
| dc.contributor.author | Karnaukh, Ella | |
| dc.contributor.author | Polikov, H. | |
| dc.contributor.author | Zavgorodniy, A. | |
| dc.date.accessioned | 2016-09-15T11:39:53Z | |
| dc.date.available | 2016-09-15T11:39:53Z | |
| dc.date.issued | 2016-09 | |
| dc.description.abstract | Modern effective drugs which are obtained by using biotechnological genetic engineering methods presented in this article. The main use in surgical and therapeutic clinical practice presents: modern recombinant probiotic generation V Subalin, which was synthesized by Ukrainian scientists for pharmacological treatment of intestinal dysbiosis, recombinant alpha-interferons Roferon-A (alfa-2a) and Altevir (alfa-2b). | ru_RU |
| dc.identifier.citation | Karnaukh E. V. Actual pharmacological biotechnological innovations to improve the quality of patient’s life therapeutic and surgical profile [Electronic resource] / E. V. Karnaukh, H. O. Polikov, A. S. Zavgorodniy // European Student Scientific Journal. – 2016. – № 2. – Access mode: sjes.esrae.ru/ru/26-376. | ru_RU |
| dc.identifier.issn | 2310-3094 | |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/13786 | |
| dc.language.iso | en | ru_RU |
| dc.subject | genetic engineering | ru_RU |
| dc.title | Actual pharmacological biotechnological innovations to improve the quality of patient’s life therapeutic and surgical profile | ru_RU |
| dc.type | Article | ru_RU |